×
About 2,093 results

ALLMedicine™ Hirsutism Center

Research & Reviews  639 results

The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics
https://clinicaltrials.gov/ct2/show/NCT04831151

May 19th, 2022 - Polycystic ovary syndrome (PCOS), is the most common endocrinological disorder that affects the reproductive aged women. In addition to causing problems such as menstrual irregularity, hirsutism, acne, it is also an important health problem that c...

Objectification and ambiguity of body image in women with Polycystic Ovary Syndrome: A ...
https://doi.org/10.1016/j.jad.2022.05.028
Journal of Affective Disorders; Yin MXC, Leng LL et. al.

May 14th, 2022 - The manifestations of Polycystic Ovary Syndrome (PCOS), including acne, hirsutism, obesity, uncertain fertility, etc., can make women anxious, worried, or even depressed with their appearance and body. However, little relevant research has been co...

The prevalence and phenotypic manifestations of polycystic ovary syndrome (PCOS) among ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102290
BMC Women's Health; Elasam AN, Ahmed MA et. al.

May 14th, 2022 - Polycystic ovary syndrome (PCOS) is a global health problem associated with significant morbidity during reproductive age. Only a few published studies that address the clinical manifestations and phenotypic presentation of the disease have been c...

Insulin resistance and idiopathic hirsutism: a systematic review, meta-analysis, and me...
https://doi.org/10.1111/jocd.15070
Journal of Cosmetic Dermatology; Amiri M, Mahmoudieh L et. al.

May 10th, 2022 - This study aimed to evaluate the Standardized Mean Difference (SMD) of insulin resistance parameters in women with IH, compared to healthy and polycystic ovary syndrome (PCOS) controls. PubMed, Scopus, Web of Sciences, and Embase were searched for...

Long-Lasting Effects of Spironolactone After its Withdrawal in Patients with Hyperandro...
https://doi.org/10.2174/1871530322666220509051746
Endocrine, Metabolic & Immune Disorders Drug Targets; Sabbadin C, Beggiao F et. al.

May 10th, 2022 - Hyperandrogenic skin disorders, such as hirsutism, acne and alopecia, affect approximately 10-20% of women of reproductive age, reducing quality of life and causing psychological impairment. Spironolactone is a commonly used antiandrogen, especial...

see more →

Guidelines  3 results

Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clin...
https://doi.org/10.1210/jc.2018-00241
The Journal of Clinical Endocrinology and Metabolism; Martin KA, Anderson RR et. al.

Mar 10th, 2018 - To update the "Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline," published by the Endocrine Society in 2008. The participants include an Endocrine Society-appointed task force of seven...

Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Andro...
https://doi.org/10.1093/humupd/dmr042
Human Reproduction Update; Escobar-Morreale HF, Carmina E et. al.

Nov 9th, 2011 - Hirsutism, defined by the presence of excessive terminal hair in androgen-sensitive areas of the female body, is one of the most common disorders in women during reproductive age. We conducted a systematic review and critical assessment of the ava...

Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clin...
https://doi.org/10.1210/jc.2007-2437
The Journal of Clinical Endocrinology and Metabolism; Martin KA, Chang RJ et. al.

Feb 7th, 2008 - Our objective was to develop clinical practice guidelines for the evaluation and treatment of hirsutism in premenopausal women. The Task Force was composed of a chair, selected by the Clinical Guidelines Subcommittee (CGS) of The Endocrine Society...

see more →

Drugs  28 results see all →

Clinicaltrials.gov  39 results

The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics
https://clinicaltrials.gov/ct2/show/NCT04831151

May 19th, 2022 - Polycystic ovary syndrome (PCOS), is the most common endocrinological disorder that affects the reproductive aged women. In addition to causing problems such as menstrual irregularity, hirsutism, acne, it is also an important health problem that c...

Microbiome and Polycystic Ovaries
https://clinicaltrials.gov/ct2/show/NCT04836910

Apr 8th, 2022 - Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder among women in reproductive age with an estimated prevalence of 5% to 19.5%. It is a chronic complex syndrome with psychological (depression and anxiety), reproductive and meta...

Prevalence of Hyperandrogenism in Type 1 Diabetes
https://clinicaltrials.gov/ct2/show/NCT04979377

Mar 29th, 2022 - Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, with an estimated prevalence of 6-15% of the general population worldwide. This heterogeneous syndrome has significant cardio-metabolic, reproduct...

The RCT of Acupuncture on PCOS Combined With IR
https://clinicaltrials.gov/ct2/show/NCT02491333

Mar 21st, 2022 - 1.1 Study design This is a randomized double blind controlled. 1.2 Subject selection and exclusion Women with PCOS and IR will be recruited from the Department of Traditional Chinese Medicine in the first affiliated hospital of Guangzhou Medical U...

Ketogenic Diet in PCOS With Obesity and Insulin Resistance
https://clinicaltrials.gov/ct2/show/NCT04801173

Jan 27th, 2022 - Consecutive patients coming to the Endocrinology and Diabetes Clinic of the S.Orsola hospital in Bologna with the suspicion of PCOS, during the study period, will be eligible to participate. In the screening phase, patients from the clinic conform...

see more →

News  118 results

Synthetic, Botanical Agents Emerging as Promising Melasma Treatments
https://www.medscape.com/viewarticle/974105

May 17th, 2022 - BOSTON — Though hydroquinone, retinoids, steroids, and triple combination cream remain gold standards for the topical treatment of melasma, new synthetic and botanical topicals are emerging as adjuvant and alternative treatments, according to Nada...

Dramatic Increase in Response With Combination for Relapsed/Resistant ITP
https://www.medpagetoday.com/hematologyoncology/hematology/96918

Jan 28th, 2022 - Patients with relapsed or corticosteroid-resistant immune thrombocytopenia (ITP) had a 33% higher response rate and 50% increase in sustained responses with all-trans retinoic acid (ATRA) plus low-dose rituximab (Rituxan), Chinese investigators re...

FDA Approves Levoketoconazole for Cushing Syndrome
https://www.medscape.com/viewarticle/965989

Jan 4th, 2022 - The US Food and Drug Administration has approved levoketoconazole (Recorlev, Xeris Biopharma) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not possible or was not curative. Endogenous Cushin...

FDA OKs First Proteinuria Drug for IgA Nephropathy
https://www.medpagetoday.com/nephrology/generalnephrology/96235

Dec 16th, 2021 - The FDA granted accelerated approval for the first drug to reduce proteinuria in primary immunoglobulin A (IgA) nephropathy, the agency announced on Wednesday. The delayed released budesonide (Tarpeyo) capsules are indicated to lower increased pro...

Birth Control Pills May Curb PCOS-Related Diabetes Risk
https://www.medpagetoday.com/endocrinology/diabetes/95053

Oct 14th, 2021 - Certain oral contraceptives were associated with a lower risk for type 2 diabetes and prediabetes in women with polycystic ovary syndrome (PCOS), according to a retrospective, population-based study. An analysis of 64,051 women with PCOS found an ...

see more →

Patient Education  10 results see all →